ENANTA PHARMACEUTICALS, INC (ENTA) Operating margin 2017–2025
ENANTA PHARMACEUTICALS, INC (ENTA) operating margin by fiscal year — reported operating income divided by reported revenue.
-130.7%FY2025 · since FY2017: 23.9% → -130.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -130.7% | +49.3 pp |
| FY2024 | -179.9% | -6.7 pp |
| FY2023 | -173.2% | -29.5 pp |
| FY2022 | -143.7% | -30.9 pp |
| FY2021 | -112.9% | -78.9 pp |
| FY2020 | -34.0% | -51.9 pp |
| FY2019 | 17.9% | -24.8 pp |
| FY2018 | 42.7% | +18.8 pp |
| FY2017 | 23.9% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More ENTA financial trends
ENTA RevenueENTA Net incomeENTA Net marginENTA Gross profitENTA Gross marginENTA Operating incomeENTA Operating cash flowENTA Free cash flowENTA Capital expendituresENTA Return on equityENTA Stock buybacksENTA Dividends paidENTA Total assetsENTA Total liabilitiesENTA Shareholders’ equityENTA overview →